dyne therapeutics

dyne therapeutics

NASDAQ:DYN
Dyne Therapeutics

Chart

Detailed Quote

Dyne Therapeutics is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Featured Articles and Interviews
Needle injecting into red and white cell.

How to Invest in Biotechnology

Press Releases

Dyne Therapeutics Appoints Barry Greene to Board of Directors

Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1

The Conversation (0)